Risk factor
Good trading liquidity
Profitability factor
Strong margins and returns
About
Qingdao Baheal Medical Inc., established in 2005 and headquartered in Qingdao, China, operates as a pharmaceutical company. The firm's activities encompass the entire spectrum of drug development, from initial research to manufacturing and sales of various medicinal products. A key offering in its portfolio is vitamin D calcium in chewable tablet form.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E
Target Price
The average target price of 301015.SZ is 27.3 and suggests 18.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to